• Share
  • Change: 0.06 SEK 15.79%
  • Bid: 0.44 SEK
  • Ask: 0.45 SEK
  • Price: 0.44 SEK
  • High: 0.45 SEK
  • Low: 0.40 SEK
  • Quantity: 281156
  • Turnover: 121981 SEK
  • Time: 2012-02-22 17:05:42
News
Feb
20
Notice of Annual General Meeting of Genovis AB (publ)
Feb
13
Genovis’ nanoparticle project published in prestigious Journal of Nuclear Medicine
Feb
7
Date change for Annual General Meeting and reports
Contact Info


Genovis AB
Box 790, SE-22007, Lund Sweden
Phone: +46(0) 46 101230
Fax: +46(0) 46 128020

Pressreleases 2011-2012

Feb
20
Notice of Annual General Meeting of Genovis AB (publ)
Feb
13
Genovis’ nanoparticle project published in prestigious Journal of Nuclear Medicine
Feb
7
Date change for Annual General Meeting and reports
Nov
24
Genovis AB nomination committee appointed
Jul
22
GENOVIS: COMMUNIQUÉ FROM EXTRA GENERAL MEETING, JULY 21, 2011
Jul
6
Notice of Extra General Meeting of Genovis AB (publ)
Jun
23
Genovis has a new majority owner
Jun
10
GENOVIS: COMMUNIQUÉ FROM ANNUAL GENERAL MEETING FOR GENOVIS AB (PUBL) June 9, 2011
May
19
Nomination Committee Proposal for 2011 Board of Directors
May
12
GENOVIS RIGHTS ISSUE 91% SUBSCRIBED
May
10
Notice of Annual General Meeting of Genovis AB (publ)
May
4
Genovis will attend several conferences in May –June 2011
Apr
20
New Product Release
Apr
6
Genovis 2010 Annual Report is Published
Apr
4
Genovis publish a new share issue prospectus
Mar
29
Report from the extraordinary general meeting of Genovis AB (publ)
Mar
28
AGM postponed and the January-March Interim Report rescheduled
Mar
9
Notice of Extra General Meeting of Genovis AB (publ)
Mar
7
Genovis’ board of directors to convene EGM and recommend that the meeting resolve to issue new shares
Feb
21
Genovis AB nomination committee appointed
Feb
16
Genovis acquires exclusive license for upconverting nanoparticles and plans launch within 1 year
Feb
14
Genovis year-end report delayed